As such, ADAM8 upregulates the HB-EGF/EGFR signaling-mediated CCL2 expression of GBM cells under TMZ treatment, subsequently inducing TAMs recruitment, which further stimulates ADAM8 upregulation of GBM cells to induce TMZ chemoresistance. This evidence concerns the gene EGFR and glioblastoma.